Different Molecular Phenotypes of Progression in - and -Like Papillary Thyroid Carcinoma

Background Papillary thyroid carcinoma (PTC) can be classified into two distinct molecular subtypes, BRAF-like (BL) and RAS-like (RL). However, the molecular characteristics of each subtype according to clinicopathological factors have not yet been determined. We aimed to investigate the gene signat...

Full description

Bibliographic Details
Main Authors: Jinsun Lim, Han Sai Lee, Jiyun Park, Kyung-Soo Kim, Soo-Kyung Kim, Yong-Wook Cho, Young Shin Song
Format: Article
Language:English
Published: Korean Endocrine Society 2023-08-01
Series:Endocrinology and Metabolism
Subjects:
Online Access:http://www.e-enm.org/upload/pdf/enm-2023-1702.pdf
_version_ 1797730946945908736
author Jinsun Lim
Han Sai Lee
Jiyun Park
Kyung-Soo Kim
Soo-Kyung Kim
Yong-Wook Cho
Young Shin Song
author_facet Jinsun Lim
Han Sai Lee
Jiyun Park
Kyung-Soo Kim
Soo-Kyung Kim
Yong-Wook Cho
Young Shin Song
author_sort Jinsun Lim
collection DOAJ
description Background Papillary thyroid carcinoma (PTC) can be classified into two distinct molecular subtypes, BRAF-like (BL) and RAS-like (RL). However, the molecular characteristics of each subtype according to clinicopathological factors have not yet been determined. We aimed to investigate the gene signatures and tumor microenvironment according to clinicopathological factors, and to identify the mechanism of progression in BL-PTCs and RL-PTCs. Methods We analyzed RNA sequencing data and corresponding clinicopathological information of 503 patients with PTC from The Cancer Genome Atlas database. We performed differentially expressed gene (DEG), Gene Ontology, and molecular pathway enrichment analyses according to clinicopathological factors in each molecular subtype. EcoTyper and CIBERSORTx were used to deconvolve the tumor cell types and their surrounding microenvironment. Results Even for the same clinicopathological factors, overlapping DEGs between the two molecular subtypes were uncommon, indicating that BL-PTCs and RL-PTCs have different progression mechanisms. Genes related to the extracellular matrix were commonly upregulated in BL-PTCs with aggressive clinicopathological factors, such as old age (≥55 years), presence of extrathyroidal extension, lymph node metastasis, advanced tumor-node-metastasis (TNM) stage, and high metastasis-age-completeness of resection-invasion-size (MACIS) scores (≥6). Furthermore, in the deconvolution analysis of tumor microenvironment, cancer-associated fibroblasts were significantly enriched. In contrast, in RL-PTCs, downregulation of immune response and immunoglobulin-related genes was significantly associated with aggressive characteristics, even after adjusting for thyroiditis status. Conclusion The molecular phenotypes of cancer progression differed between BL-PTC and RL-PTC. In particular, extracellular matrix and cancer-associated fibroblasts, which constitute the tumor microenvironment, would play an important role in the progression of BL-PTC that accounts for the majority of advanced PTCs.
first_indexed 2024-03-12T11:51:30Z
format Article
id doaj.art-5a8cc9104e434d9fa74cd383e9a089b6
institution Directory Open Access Journal
issn 2093-596X
2093-5978
language English
last_indexed 2024-03-12T11:51:30Z
publishDate 2023-08-01
publisher Korean Endocrine Society
record_format Article
series Endocrinology and Metabolism
spelling doaj.art-5a8cc9104e434d9fa74cd383e9a089b62023-08-31T07:16:44ZengKorean Endocrine SocietyEndocrinology and Metabolism2093-596X2093-59782023-08-0138444545410.3803/EnM.2023.17022405Different Molecular Phenotypes of Progression in - and -Like Papillary Thyroid CarcinomaJinsun Lim0Han Sai Lee1Jiyun Park2Kyung-Soo Kim3Soo-Kyung Kim4Yong-Wook Cho5Young Shin Song6 Department of Medicine, CHA University School of Medicine, Seongnam, Korea Department of Biomedical Science, Graduate School, CHA University, Seongnam, Korea Department of Medicine, CHA University School of Medicine, Seongnam, Korea Department of Medicine, CHA University School of Medicine, Seongnam, Korea Department of Medicine, CHA University School of Medicine, Seongnam, Korea Department of Medicine, CHA University School of Medicine, Seongnam, Korea Department of Medicine, CHA University School of Medicine, Seongnam, KoreaBackground Papillary thyroid carcinoma (PTC) can be classified into two distinct molecular subtypes, BRAF-like (BL) and RAS-like (RL). However, the molecular characteristics of each subtype according to clinicopathological factors have not yet been determined. We aimed to investigate the gene signatures and tumor microenvironment according to clinicopathological factors, and to identify the mechanism of progression in BL-PTCs and RL-PTCs. Methods We analyzed RNA sequencing data and corresponding clinicopathological information of 503 patients with PTC from The Cancer Genome Atlas database. We performed differentially expressed gene (DEG), Gene Ontology, and molecular pathway enrichment analyses according to clinicopathological factors in each molecular subtype. EcoTyper and CIBERSORTx were used to deconvolve the tumor cell types and their surrounding microenvironment. Results Even for the same clinicopathological factors, overlapping DEGs between the two molecular subtypes were uncommon, indicating that BL-PTCs and RL-PTCs have different progression mechanisms. Genes related to the extracellular matrix were commonly upregulated in BL-PTCs with aggressive clinicopathological factors, such as old age (≥55 years), presence of extrathyroidal extension, lymph node metastasis, advanced tumor-node-metastasis (TNM) stage, and high metastasis-age-completeness of resection-invasion-size (MACIS) scores (≥6). Furthermore, in the deconvolution analysis of tumor microenvironment, cancer-associated fibroblasts were significantly enriched. In contrast, in RL-PTCs, downregulation of immune response and immunoglobulin-related genes was significantly associated with aggressive characteristics, even after adjusting for thyroiditis status. Conclusion The molecular phenotypes of cancer progression differed between BL-PTC and RL-PTC. In particular, extracellular matrix and cancer-associated fibroblasts, which constitute the tumor microenvironment, would play an important role in the progression of BL-PTC that accounts for the majority of advanced PTCs.http://www.e-enm.org/upload/pdf/enm-2023-1702.pdfthyroid cancer, papillarytranscriptomegene expression profilingtumor microenvironment
spellingShingle Jinsun Lim
Han Sai Lee
Jiyun Park
Kyung-Soo Kim
Soo-Kyung Kim
Yong-Wook Cho
Young Shin Song
Different Molecular Phenotypes of Progression in - and -Like Papillary Thyroid Carcinoma
Endocrinology and Metabolism
thyroid cancer, papillary
transcriptome
gene expression profiling
tumor microenvironment
title Different Molecular Phenotypes of Progression in - and -Like Papillary Thyroid Carcinoma
title_full Different Molecular Phenotypes of Progression in - and -Like Papillary Thyroid Carcinoma
title_fullStr Different Molecular Phenotypes of Progression in - and -Like Papillary Thyroid Carcinoma
title_full_unstemmed Different Molecular Phenotypes of Progression in - and -Like Papillary Thyroid Carcinoma
title_short Different Molecular Phenotypes of Progression in - and -Like Papillary Thyroid Carcinoma
title_sort different molecular phenotypes of progression in and like papillary thyroid carcinoma
topic thyroid cancer, papillary
transcriptome
gene expression profiling
tumor microenvironment
url http://www.e-enm.org/upload/pdf/enm-2023-1702.pdf
work_keys_str_mv AT jinsunlim differentmolecularphenotypesofprogressioninandlikepapillarythyroidcarcinoma
AT hansailee differentmolecularphenotypesofprogressioninandlikepapillarythyroidcarcinoma
AT jiyunpark differentmolecularphenotypesofprogressioninandlikepapillarythyroidcarcinoma
AT kyungsookim differentmolecularphenotypesofprogressioninandlikepapillarythyroidcarcinoma
AT sookyungkim differentmolecularphenotypesofprogressioninandlikepapillarythyroidcarcinoma
AT yongwookcho differentmolecularphenotypesofprogressioninandlikepapillarythyroidcarcinoma
AT youngshinsong differentmolecularphenotypesofprogressioninandlikepapillarythyroidcarcinoma